Sign in to view Einat’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Sign in to view Einat’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
San Francisco Bay Area
Sign in to view Einat’s full profile
Einat can introduce you to 10+ people at Illumina
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
6K followers
500+ connections
Sign in to view Einat’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
View mutual connections with Einat
Einat can introduce you to 10+ people at Illumina
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
View mutual connections with Einat
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Sign in to view Einat’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
About
Welcome back
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
Articles by Einat
-
Illuminating Rare Disease Day 2022
Illuminating Rare Disease Day 2022
Today is Rare Disease Day. At Illumina, we spend the entire month of February raising awareness to improve access and…
70
1 Comment
Activity
6K followers
-
Einat Metzer shared thisThe past decade has taken me through different vantage points on building and scaling businesses. From a career in VC, to founding an AI data analytics company in life sciences, to corporate leadership roles at the intersection of AI, data platforms and regulated industries. I recently sat down with David Leichner on his Hot-in-Tech podcast to reflect on some of the insights I gained along the way. We spoke about the costly pitfall of deploying AI into human-centered processes, the radical startup-to-enterprise transition in M&A (from “running at sprint pace” to sometimes “walking in sand”), and the inherent challenge in AI deployments (building trust with customers: hard to build, easy to lose). We also spoke about climbing mountains in Nepal, and what my 14-year-old daughter told me about being an aspiring entrepreneur in today’s world (wiser than her age!) Thanks for a lovely conversation, David Leichner! https://lnkd.in/ggVHWrWJ #EnterpriseAI #BusinessTransformation #MergersAndAcquisitionsBuilding AI Companies That Last: Strategy, Trust, and Responsibl…Building AI Companies That Last: Strategy, Trust, and Responsibl…
-
Einat Metzer shared thisAs the pace at which genomic data is generated accelerates, AI-enabled interpretation is key to unlocking insights, and enabling better patient care. Proud of my team and our Baylor collaborators for demonstrating the accuracy of such approach and the scale it offers in a market undergoing rapid growth. Thank you Genetics in Medicine for the acknowledgement! It's on all of us to keep driving this field forward! Shay Tzur Niv Mizrahi Ruben Attali Yakir Regev Tomer Talmy Fan Xia, PhD, FACMGG Linyan Meng , PhD, FACMG https://lnkd.in/dBGKZ3fNEvaluation of an automated genome interpretation model for rare disease routinely used in a clinical genetic laboratoryEvaluation of an automated genome interpretation model for rare disease routinely used in a clinical genetic laboratory
-
Einat Metzer shared thisEinat Metzer shared this
-
Einat Metzer shared this#IlluminaAccelerator will be meeting with the Israeli startups community next week - a great opportunity to connect with Amanda Cashin, PhD and her wonderful team. Illumina #israelinnovationEinat Metzer shared thisIsrael: Join AION Labs, #IlluminaAccelerator, and genomics entrepreneurs from Israel for a digital meetup sharing advice & lessons learned in building breakthrough life science companies! Hear first hand from Illumina For Startups, NewStem Ltd., Futura Genetics, AION Labs, Pfizer, and Arkin Holdings for an interactive panel discussion on March 10th at 11 am IST/9 am GMT! #genomics #startups #entrepreneurs #seedfunding StartupIsrael Illumina
-
Einat Metzer shared thisIn honor of rare disease day I'm thrilled to share the work that the newly formed Israeli Center of Excellence has been doing at Illumina to increase access to diagnosis for the 300M rare disease patients around the world. Today and every day our mission continues to shorten the diagnosis odyssey for patients and their families and enabling better care. #rarediseaseday2022 #illuminatingraredisease #israelinnovation
-
Einat Metzer shared thisTechCrunch featured our perspective on how cognitive genomics tech can deliver an accurate first-line analysis of human DNA in the context of clinical care. Excited about what the future holds! #genomics #artificialintelliegence Emedgene https://hubs.li/H0MWy340
-
Einat Metzer shared thisSo proud of my team! #culturematters EmedgeneEinat Metzer shared thisWhen I first started working at Emedgene, I didn't realize how much it would mean to me to work for an international company at this point in my life/career. The past years in the US have made me realize that the division in my country is about more than a single election. I am grateful to have this connection to humans from so many different countries, languages, continents, so many different religions, beliefs at this point in time. I am grateful that the culture in my company encourages sharing those differences in lifestyle- celebrating the good- weddings half way around the world, new babies, holidays I never heard of- and sharing the tough times- an earthquake in India that I didn't read about in western media, memorial day in a country where everyone serves in the military, a diagnostic journey. My favorite thing about working at Emedgene is when I get to tackle a genomics challenge on our internal communication tool with colleagues in the Ukraine, Israel, India and beyond, in different time zones, but connected by work. The transition from academia to a startup has been an eye opener about myself and my career, a step outside my comfort zone for sure, but I am so happy to have found this company, these people, even if I have never met them facetoface. #culturematters
-
Einat Metzer shared thisA global pandemic of a different kind. Over 300M WW. 50% children. I say enough. Let's get this done! Thanks #forbestechcouncil for sharing our story. #rarediseaseday2021 #genetics EmedgeneEinat Metzer shared thisAre rare diseases healthcare’s next 4-minute mile? COVID-19 taught us that rapid healthcare innovation is possible. This #rarediseaseday, let's set a target to end the diagnostic odyssey for millions of patients in need. Read on Forbes by Emedgene CEO Einat Metzer Forbes Technology Council https://hubs.li/H0Hj9dK0
-
Einat Metzer shared thisIt's Rare Disease Day - a reminder of what's not rare at all. In fact, there are more people with rare diseases than people with AIDS and Cancer combined. It was difficult to diagnose them in the past as we were limited by human capacity. But today, finally, we have technology that can scale to millions. 50% children. Many in life-threatening situations. I say enough. Let's get this done! Emedgene #rarediseaseday2021 #genetics #artificialintelliegence Thanks #forbestechcouncil for sharing our mission!
-
Einat Metzer reacted on thisEinat Metzer reacted on thisWhen Eyal Lifshitz and I started Bluevine 13 years ago, we believed technology could fundamentally improve the way small businesses access and manage financial services. Today marks a major milestone in that journey: Bluevine has signed an agreement to be acquired by Valley National Bancorp, the parent company of Valley Bank I’m especially proud that the technology we’ve built — and the incredible engineering, product, data and AI teams behind it — are an important part of what brings our companies together. We’ve spent years building a modern platform designed to move quickly, solve complex financial problems and deliver better experiences for small business owners. Joining Valley gives us the opportunity to bring those capabilities to a much larger banking organization and expand what we can build from here. I’m incredibly proud of this team and excited for the next chapter. Read the announcement: https://lnkd.in/d9gtgJJwValley National Bancorp to Acquire Bluevine Inc., Accelerating its Digital Small Business Growth Strategy and Meaningfully Enhancing its Core Funding Capabilities | BluevineValley National Bancorp to Acquire Bluevine Inc., Accelerating its Digital Small Business Growth Strategy and Meaningfully Enhancing its Core Funding Capabilities | Bluevine
-
Einat Metzer reacted on thisEinat Metzer reacted on thisSmall business has always been personal to me. My father and grandfather were both small business owners, and 13 years ago Nir Klar and I started Bluevine because we believed small business owners deserved better financial services. Today, we've announced a major milestone in that journey: Bluevine has signed an agreement to be acquired by Valley National Bancorp, the parent company of Valley Bank. What started with helping small businesses access working capital has grown into the largest small business banking platform in the country. We've served more than 1 million small businesses, delivered more than $17 billion in financing, expanded into banking and payments, and built an incredible team around the world. We've always made decisions based on how we can deliver the greatest impact for small business owners. We believe this decision will also have a great impact for these owners. Valley brings the scale, stability, capabilities, and reach of an established bank. Combined with Bluevine's technology, small business expertise, and digital-first customer experience, we believe it will allow us to accelerate our growth and advance the mission we've been pursuing from the beginning. I couldn't be prouder of what our team has built over the past 13 years, or more energized by what we can build from here. Thank you to our customers for trusting us with your businesses, and to every Blueviner past and present who helped get us to this moment. Read the full announcement: https://lnkd.in/gFbCmGH5Valley National Bancorp to Acquire Bluevine Inc., Accelerating its Digital Small Business Growth Strategy and Meaningfully Enhancing its Core Funding Capabilities | BluevineValley National Bancorp to Acquire Bluevine Inc., Accelerating its Digital Small Business Growth Strategy and Meaningfully Enhancing its Core Funding Capabilities | Bluevine
-
Einat Metzer liked thisClaude Opus 5.5 is smarter than Fable 5.1, faster and cheaper than Opus 5, and a much better communicator, which makes it more enjoyable to talk to and collaborate with. I've been using Opus 5.5 to explain concepts in biology and critique my strategic thinking. It's a good model and I hope you enjoy using it!Einat Metzer liked thisWe’re introducing Claude Opus 5.5, the first model in our new Claude 5.5 family. It performs at the level of Claude Fable 5.1 for most tasks, and costs 40% less to run than Opus 5. Opus 5.5 is our first model since we called for pacing the frontier. As with previous models, it was tested by external evaluators before release, including METR and Frontier Design. On our most comprehensive alignment test, it achieves the strongest score to date. It outperforms both Opus 5 and Fable 5.1 on nearly every benchmark we report, leading on agentic coding and real-world knowledge work. It’s also more efficient. Opus 5.5 uses fewer tokens per task at a lower price per token, and generates output more than 30% faster than Opus 5. Opus 5.5 communicates more naturally, addressing some of the most common feedback we heard on Opus 5. It puts the most important information up front and follows the writing rules you give it. Claude Opus 5.5 is available today. We're also raising five-hour limits on Pro, Max, and Team plans, so there’s more room to explore what it can do. Read more: https://lnkd.in/ed8v38cg
-
Einat Metzer liked thisEinat Metzer liked thisToday we’re launching the Life Science Verification Program, enabling life science professionals to use Mythos-class models in biology-related work for the first time. Applications are open here: https://lnkd.in/ggeUUdXp Over the past few months, we’ve been hard at work developing a new set of safeguards that provide a better experience for those doing biology work, while also providing more protection for our users against the increasingly sophisticated attempts at misuse that we’ve been seeing on our platform. Reach out if you have any trouble with the enrollment process.
-
Einat Metzer reacted on thisEinat Metzer reacted on thisThe saying goes, "We’re meant to work to live, not live to work." But some of us hit the jackpot and find jobs that are challenging yet also fun, deeply fulfilling, and filled with purpose. Illumina has been that for me, and I’m very grateful. Today is my last day after 13 wonderful years. I’ve had the privilege of working alongside deeply thoughtful people whose scientific and engineering brilliance is matched by a sincere passion for improving human health. There is a spirit here of pushing the bounds of what is possible, imagining a better future for human health and scientific discovery, and driving the collaboration and creativity needed to turn that vision into reality. There is an energy here that is hard to put into words unless you’ve been lucky enough to experienced it yourself. The friendships I’ve made and the lessons I’ve learned have truly been a gift. I’ve been incredibly fortunate to have many extraordinary (and entertaining) colleagues and mentors along the way. So much of who I am today has been shaped by those relationships, and I’m so deeply appreciative. I cannot wait to see the important and super cool stuff you’ll continue to do, and I wish you all continued success. I’m looking forward to taking a couple of weeks off before starting a new role. I’m very excited about my next opportunity, but today I’m filled with gratitude for an amazing 13 years.
Experience & Education
-
BrilliantlySo
****** ******** ********* * ********** ** * ********* ***********
-
********
**** ********* * **** ** ****** ********* ******
-
********* ** ******** *******
** ******* * ***** ********* *******
-
*** ****** **********
******** ** ******* * ** ******** ******* *** ********* undefined
View Einat’s full experience
See their title, tenure and more.
Welcome back
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
or
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Volunteer Experience
-
Board Member
The Sky is the Limit
- 2 years 11 months
Children
Advising a non-for-profit focused on empowering teenagers from challenged background through social entrepreneurship
Honors & Awards
-
Prime Minister Award of Innovation
Israel's Prime Minister Office
-
Prominent Industry Leader
The Marker Magazine
Named one of the Top-40 Israeli most promising hi-tech industry leaders by TheMarker Magazine.
Organizations
-
Yazamiyot
Co-Founder
-The leading Israeli network for female entrepreneurs.
View Einat’s full profile
-
See who you know in common
-
Get introduced
-
Contact Einat directly
Other similar profiles
-
Stuart McLeod
Stuart McLeod
As a seasoned entrepreneur with a track record of building category-defining software, I'm focused on transforming how accounting gets done. I'm currently co-founder and CEO of Archie, where we're building an AI-powered accountant workforce that works alongside human teams to reimagine what's possible in modern accounting firms.<br><br>My path in accounting tech runs deep. In 2014, I founded Karbon Inc, a workstream collaboration platform designed specifically for accountants. As CEO, I leveraged over 15 years of experience in software development, sales, support, and product management to grow Karbon into a global platform that's driving meaningful industry change at scale.<br><br>Before Karbon, I co-founded Paycycle in 2011—an online payroll solution tailored for the Australian market. After two years of dedicated development, Paycycle was acquired by Xero. I played a pivotal role in integrating the technology and expertise, leading a team of 60 engineers and product managers to launch seamless payroll solutions across Australia, the United States, New Zealand, and the United Kingdom.<br><br>With Archie, I'm bringing together everything I've learned about the accounting industry with the transformative potential of AI. We're not just building another tool—we're creating AI teammates that can handle the work, allowing human accountants to focus on strategy, relationships, and the judgment calls that truly matter.<br><br>The journey continues, and I'm as committed as ever to fostering entrepreneurial talent and leading teams toward achieving extraordinary goals. The companies I've built—Paycycle, Karbon, and now Archie—aren't just businesses; they're catalysts for industry transformation.<br><br>🔗 Let's connect! I'm always open to discussing the future of accounting technology, AI workforce innovation, or sharing insights from my journey in building B2B SaaS companies.
6K followersOakham
Explore more posts
-
Gary M. Austin
4K followers
Former Drawbridge Health CEO Launches Manifold Health AI at JPM to Build the First Digital Health Index Twin for Chronic Disease. SAN FRANCISCO, Jan. 13, 2026 /PRNewswire/ -- Manifold Health AI today announced its launch at JPM Healthcare Week and the GMT MedTech Symposium, unveiling a first-to-market platform that combines a novel, precision-designed blood test with an AI-driven Digital Health Index Twin to translate biological data into financial risk intelligence for healthcare infrastructure. The announcement was delivered by Manifold's Founder and CEO, Jerome Scelza. This will fundamentally change health risk management, improve health outcomes, and make healthcare affordable again. For the complete press release: https://lnkd.in/e9NsnRiT Message me if you would like to know more!
5
-
Lisa Piercey
National HealthCare… • 5K followers
FORCING CHANGE IN SITE OF CARE McKinsey & Company's recent paper on the forces pressuring healthcare, including the possibility of margin compression of up to 13 percentage points for health systems, does a good job of putting numbers around what most operators already feel. Two of the biggest drivers they mention are policy shifts in reimbursement and rising utilization driven by an aging population. The cohort of 70+ year old Americans will grow the fastest over the next 5 years, and it is well established that older patients have more complex needs, more chronic disease, and more touchpoints within the healthcare system. Layer that on top of continued clinical workforce shortages, and the supply-demand gap widens further. From my perspective, optimizing for site of care is the most important lever we have to address this challenge. We can’t quickly reduce how much care older patients need, but we can change where and how services are delivered. Supporting aging patients in lower-cost settings like the home, ambulatory sites, and virtual environments is no longer just a preference or convenience, it’s a necessity. This is where the conversation around site-neutral payments becomes so relevant. CMS is moving quickly in this direction, and hospital outpatient departments (HOPDs) are squarely in the crosshairs. The shift will undoubtedly clamp down further on hospital margins, but it shouldn’t be surprising. We’ve been talking about the demise of HOPD reimbursement for years, and the health systems that will fare best are the ones who are working towards aligning their approach with where patients can be treated safely, efficiently, and at lower cost, rather than relying on legacy reimbursement structures to fill the gap. And just like it doesn’t make sense to try to replicate a hospital or nursing home environment in a patient’s home, we also shouldn’t try to carry the same clinical staffing model into every care setting. Yes, there are non-negotiables when it comes to patient safety and clinical expertise, but there’s also a meaningful opportunity to rethink how teams are built. That means clinicians at every level working at the top of their licenses, thoughtfully involving family members and community resources, and using technology to surround these sites of care with non-clinical operational support. From my health system days, I understand why rising costs, margin pressure, and site-neutral payments feel like threats. While painful, I’m hopeful they can also serve as a positive forcing function, pushing us toward care models that are better aligned with our aging population and the realities of today’s workforce.
24
1 Comment -
Darian Shirazi
Gradient • 22K followers
Nice quote from one of our Partners Andrew Brackin in TechCrunch: “This was one of the biggest use cases of ChatGPT,” Andrew Brackin, a partner at Gradient who invests in health tech, told TechCrunch. “So it makes a lot of sense that they would want to build a more kind of private, secure, optimized version of ChatGPT for these healthcare questions.” https://lnkd.in/gY3TV5VD
27
1 Comment -
Daniel Karsberg
HealthCap • 5K followers
Distribution is becoming the moat in healthcare AI Anthropic’s recent Claude for Healthcare update was a good example: the main features were not focused on model performance, it was connectivity, making Claude usable inside the healthcare enterprise stack. The main drops were: -> Coverage rules (CMS Coverage Database connector): check whether a treatment is reimbursable and under what conditions -> Coding (ICD-10 connector): translate clinical language into billing/diagnosis codes -> Provider verification (NPI Registry connector): validate provider identity for credentialing and claims -> Prior Authorization Agent: assemble documentation and rationale for approvals/appeals -> Interoperability tooling: make it easier to plug into health IT systems This shift creates real opportunity for founders. Healthcare is fragmented by country, system, and workflow, so teams that can embed applications deeply in specific workflows can build meaningful markets, even from narrow starting points. Source: https://lnkd.in/dFEi8UDP
12
2 Comments -
Inna Sheyn
Aramis Advisors • 5K followers
𝗗𝘂𝗼𝘀 𝗥𝗮𝗶𝘀𝗲𝘀 $𝟭𝟯𝟬𝗠 𝘁𝗼 𝗔𝗱𝘃𝗮𝗻𝗰𝗲 𝗔𝗜 𝗳𝗼𝗿 𝗦𝗲𝗻𝗶𝗼𝗿 𝗛𝗲𝗮𝗹𝘁𝗵 𝗡𝗮𝘃𝗶𝗴𝗮𝘁𝗶𝗼𝗻 Duos has secured $130M in growth equity led by FTV Capital and Forerunner Ventures to expand its AI platform and partnerships across Medicare Advantage, Medicaid, and ACA plans. The funding will enhance Duos’ Chat 2.0 AI, which uses Retrieval Augmented Generation to deliver multilingual, CMS-compliant, and personalized guidance for seniors while combining automation with a human touch. The company already serves more than 15M Medicare Advantage members through collaborations with Humana (HUM), Magellan Healthcare, and Geisinger Health Plan. The investment underscores AI’s growing role in the $9T longevity economy. Duos helps older adults live independently by connecting them to health plan benefits, community programs, and support services that improve access, coordination, and confidence in managing their care. https://lnkd.in/eW4sYSNA
-
Ken Nelson
Echo IQ • 19K followers
Cardiology and Electrophysiology have been trailblazers on the healthcare Artificial Intelligence front and below are a few examples of disruptive startups that are either pure AI plays or emerging AI enabled devices: HeartBeam Inc. (NASDAQ: BEAT) EchoIQ Acarix AccurKardia StimCardio Medical (formerly CardiaCare) SmartCardia Happitech Octagos Galenband Bloomlife Inc MedTech Innovator LSI American Heart Association Heart Rhythm Society HRX #epeeps #artificialintelligence #digitalhealth HeartX Accelerator American College of Cardiology MedAxiom - An ACC Company European Society of Cardiology EHRA President
36
5 Comments -
Joshua Liu, MD
AMS Healthcare • 30K followers
It took SeamlessMD 10+ years to reach scale as a Health Tech company. Here were the 3 HARDEST things we had to learn along the way: 𝟭/ 𝗬𝗼𝘂 𝗰𝗮𝗻 𝗴𝗮𝗶𝗻 𝗮𝗻𝗱 𝗹𝗼𝘀𝗲 𝗽𝗿𝗼𝗱𝘂𝗰𝘁-𝗺𝗮𝗿𝗸𝗲𝘁 𝗳𝗶𝘁. 𝗬𝗼𝘂 𝗵𝗮𝘃𝗲 𝘁𝗼 𝗰𝗼𝗻𝘀𝘁𝗮𝗻𝘁𝗹𝘆 𝗿𝗲𝗶𝗻𝘃𝗲𝗻𝘁 𝘁𝗵𝗲 𝗰𝗼𝗺𝗽𝗮𝗻𝘆’𝘀 𝗽𝗿𝗼𝗱𝘂𝗰𝘁, 𝗴𝗼-𝘁𝗼-𝗺𝗮𝗿𝗸𝗲𝘁 𝗮𝗻𝗱 𝗺𝗼𝗿𝗲. Pre-COVID it was all about having the strongest clinical evidence and getting bottom up, physician champion buy-in -no one else in the org really cared to own our product. Post-COVID, it was all about aligning with CMIOs/CIOs/Digital/Operational Execs. On the one hand, that gave us a path to system-wide scale. On the other hand, it led to increased competition, making the product stand out more beyond industry-best clinical evidence and more complex sales cycles. I remember telling our investors back in 2021 it “felt” like this transition from bottom-up to top-down adoption was happening, but navigating it was a whole other experience. 𝟮/ 𝗛𝗲𝗮𝗹𝘁𝗵 𝗧𝗲𝗰𝗵 𝗶𝘀 𝗮 𝗹𝗼𝗻𝗴-𝘁𝗲𝗿𝗺 𝗴𝗮𝗺𝗲 𝗯𝗮𝘀𝗲𝗱 𝗼𝗻 𝗹𝗼𝗻𝗴-𝘁𝗲𝗿𝗺 𝗿𝗲𝗹𝗮𝘁𝗶𝗼𝗻𝘀𝗵𝗶𝗽𝘀. 𝗡𝗼 𝘀𝗵𝗼𝗿𝘁𝗰𝘂𝘁𝘀. 𝗝𝘂𝘀𝘁 𝘀𝗵𝗼𝘄𝗶𝗻𝗴 𝘂𝗽 𝗲𝘃𝗲𝗿𝘆 𝗱𝗮𝘆 𝗮𝗻𝗱 𝗹𝗲𝘁𝘁𝗶𝗻𝗴 𝘀𝗺𝗮𝗹𝗹 𝘄𝗶𝗻𝘀 𝗰𝗼𝗺𝗽𝗼𝘂𝗻𝗱. Innovators get frustrated early on in the startup journey - many folks will take meetings with you because they are truly excited by your vision - but the complexity and low-margin environment of healthcare mean that most of those meetings won’t go anywhere… yet. Yet many times we’ve secured new health system partnerships based on individual relationships started many, many years before. If we had given up earlier, those partnerships would never have happened. 𝟯/ 𝗡𝗼 𝗼𝗻𝗲 𝗯𝗲𝗹𝗶𝗲𝘃𝗲𝘀 𝘄𝗵𝗮𝘁 𝘁𝗵𝗲 𝗰𝗼𝗺𝗽𝗮𝗻𝘆 𝘀𝗮𝘆𝘀. 𝗧𝗵𝗲 𝗼𝗻𝗹𝘆 𝘄𝗼𝗿𝗱 𝘁𝗵𝗮𝘁’𝘀 𝘁𝗿𝘂𝗹𝘆 𝘁𝗿𝘂𝘀𝘁𝗲𝗱 𝗶𝘀 𝘁𝗵𝗮𝘁 𝗼𝗳 𝗼𝘁𝗵𝗲𝗿 𝗵𝗲𝗮𝗹𝘁𝗵 𝘀𝘆𝘀𝘁𝗲𝗺𝘀 - 𝘀𝗼 𝗳𝗼𝗰𝘂𝘀 𝗼𝗻 𝗺𝗮𝗸𝗶𝗻𝗴 𝗵𝗲𝗮𝗹𝘁𝗵 𝘀𝘆𝘀𝘁𝗲𝗺𝘀 𝘀𝘂𝗰𝗰𝗲𝘀𝘀𝗳𝘂𝗹. Early on I thought my job was to be the biggest mouthpiece for the company - get on every stage possible to preach the vision and success of the company - I mean, isn’t that what happened in every other tech industry? In Healthcare, it’s the complete opposite - vendors on stage are distrusted. Evidence they share is picked apart, even if it’s evidence developed independently by reputable healthcare organizations. The most powerful marketing occurs when your health system customers, on their own, present, publish and share their success with you. And the best way to make that happen is to focus on making them successful. The challenge? This takes TIME - often a year or two or more - if ever. *** Reflecting on these, the common themes are Resilience and Patience. There’s no secret formula. No magic framework. It’s simply caring about solving the problem more than anyone else, and having the fortune of finding brilliant teammates who care just as much.
41
7 Comments -
Andrew Lombard
TESORO VC • 7K followers
Excited to announce a new collaboration between MDM2 and Tesoro Venture Capital focused on accelerating the commercialization of next-generation healthcare innovation. This initiative is designed to help promising MedTech companies move beyond innovation and into real-world adoption by connecting founders with clinical validation, industry partners, capital, regulatory guidance, manufacturing support, and market access. At Tesoro VC, we believe the biggest opportunity is not simply identifying breakthrough technologies—it is building the ecosystem required to help those technologies reach patients, providers, and markets at scale. Together with MDM2, we are creating a stronger commercialization pathway for healthcare innovators while further strengthening Arizona’s position as an emerging hub for MedTech, AI, advanced technologies, and healthcare innovation. Looking forward to working with founders, healthcare systems, industry leaders, investors, and strategic partners as we build this initiative. Kiran Avancha, PhD Steven Lester MD Aric H. Bopp, CEcD Kathleen Lee Chris Yoo Stuart Broyles, PhD Wes Gullett Mike Self Matthew Puopolo #MedTech #HealthcareInnovation #VentureCapital #Commercialization #DigitalHealth #AI #MedicalDevices #ArizonaInnovation #Startups #TesoroVC
64
8 Comments
Explore top content on LinkedIn
Find curated posts and insights for relevant topics all in one place.
View top content